Lower riskDrug recall · FDA · Published October 11, 2024
Padagis Triamcinolone Cream Recall: Subpotent Drug Risk
Padagis recalls triamcinolone acetonide cream due to subpotent and superpotent drug issues found in stability testing. This affects specific lot numbers and expiration dates.
Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.
Take action
Contact the company
📍Recalling firmPadagis US LLC3940 Quebec Ave N · Minneapolis, MN 55427-1244
“Padagis Triamcinolone Cream Recall: Subpotent Drug Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32508-padagis-triamcinolone-cream-recall-subpotent-drug-risk. Based on FDA recall #D-0048-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0048-2025%22&limit=1).
Padagis US LLC voluntarily recalled Triamcinolone Acetonide Cream USP, 0.025%, 1 LB jars nationwide due to subpotent and superpotent drug risks, the FDA said on Oct. 11, 2024. The recall involves 10,872 jars distributed across the U.S.
How to tell if you have it
Brand: Padagis
Product: Triamcinolone Acetonide Cream USP, 0.025%, 1 LB (454 g) per jar, Rx Only
NDC: 45802-0063-05
Lot #: 2024154238, 2024174344
Exp. Date: 3/31/2026
Manufacturer: Padagis, Minneapolis, MN 55427
The hazard
The recall addresses subpotent and superpotent drug risks caused by out-of-specification assay results recorded during long-term stability testing for the Uniformity of Container test. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Padagis US LLC has issued seven other recalls since Dec. 27, 2021. Recent brand recalls include a June 23, 2026 Nystatin Cream recall for subpotent drug risk and a Feb. 6, 2025 Estradiol Gel recall for defective containers allowing ethanol loss. Other recent recalls of similar products include Blaine Labs TERPENICOL Antifungal Cream (April 8, 2026), CoValence Laboratories Remedy Gel Hydrocortisone 1% (March 18, 2026), and Sun Pharmaceutical Fluocinonide Cream (March 25, 2026).
How to tell if you have this one
Check for the brand 'Padagis', product name 'Triamcinolone Acetonide Cream USP 0.025%', and lot numbers 2024154238 or 2024174344. The expiration date is March 31, 2026.
Brand
Padagis
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot numbers 2024154238 or 2024174344 on the jar's label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0048-2025 (October 11, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0048-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.